Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma.
Bartlett NL, Hahn U, Kim WS, Fleury I, Laribi K, Bergua JM, Bouabdallah K, Forward N, Bijou F, MacDonald D, Portell CA, Ghesquieres H, Nowakowski G, Yasenchak CA, Patterson M, Ho L, Rustia E, Fanale M, Jie F, Kim JA.
Bartlett NL, et al. Among authors: patterson m.
J Clin Oncol. 2025 Jan 7:JCO2402242. doi: 10.1200/JCO-24-02242. Online ahead of print.
J Clin Oncol. 2025.
PMID: 39772655